Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introducing Glycomet-GP 0.5 Tablet SR, a powerful combination medication belonging to the category of anti-diabetic drugs. Specifically formulated to treat type 2 diabetes mellitus in adults, this medication plays a crucial role in controlling blood sugar levels and is an integral part of a comprehensive diabetes management plan.
Glycomet-GP 0.5 Tablet SR is designed to be taken with food, ideally at the same time every day, ensuring maximum benefits. Your doctor will determine the most suitable dosage, adjusting it based on your glucose levels. It is imperative to continue taking this medication, even if you feel well or your glucose levels are under control. Stopping it without consulting your doctor may lead to elevated glucose levels, putting you at risk of kidney damage, blindness, nerve problems, and limb loss.
Medical Uses:
Glycomet-GP 0.5 Tablet for Type 2 Diabetes Mellitus
Unlocking the Benefits:
Glycomet-GP 0.5 Tablet SR, a combination medication, enhances insulin production in the pancreas, working to lower blood glucose levels. Administered once a day, it forms an integral part of your treatment program. Maintaining optimal blood glucose levels is pivotal in managing diabetes, significantly reducing the risk of serious complications such as kidney damage, eye issues, nerve problems, and limb loss. Regular use, combined with a balanced diet and exercise, facilitates a normal, healthy life.
Mechanism of Action:
How Glycomet-GP 0.5 Tablet Works
Glycomet-GP 0.5 Tablet SR combines two antidiabetic medications: Glimepiride and Metformin. Glimepiride, a sulfonylurea, increases insulin production in the pancreas to lower blood glucose levels. Metformin, a biguanide, lowers glucose production in the liver, delays glucose absorption from the intestines, and enhances the body's sensitivity to insulin.